Prospeo
Hero Section BackgroundHero Section Background
Scinai Immunotherapeutics

Scinai Immunotherapeutics Email Formats

Biotechnology ResearchFlag of ILMate Yehuda Regional Council, Jerusalem District, Israel21-50 Employees

Scinai Immunotherapeutics Email Formats

Scinai Immunotherapeutics uses 5 email formats. The most common is {first initial}.{last name} (e.g., j.doe@scinai.com), used 27.3% of the time.

FormatExamplePercentage
{first initial}.{last name}
j.doe@scinai.com
36.4%
{first name}
john@biondvax.com
27.3%
{last name}
doe@biondvax.com
13.6%
{first name}.{last name}
john.doe@biondvax.com
9.1%

Key Contacts at Scinai Immunotherapeutics

Flag of IL

Solomon Gahtan

Director Cdmo Bd & Sales

Flag of IL

Amir Reichman

Chief Executive Officer

Flag of IL

Oded Ovadia

Director,Analytics And Preclinical Trials

Flag of IL

Tehila Sonnenfeld

Director Of Production

Flag of IL

George Lowell

Member Board Of Directors

Company overview

HeadquartersMate Yehuda Regional Council, Jerusalem District, Israel
Phone number+97289302529
Website
NAICS541714
Keywords
Biotechnology, Pharmaceutical, Clinical Trials, GMP, Therapeutics, Infectious Diseases, Antibodies, Pharmaceutical Manufacturing, Immunotherapeutics, Cdmo, Recombinant Proteins, GXP, Nasdaq, Biondvax, Nanobodies, Nanoabs, Scinai
Employees21-50
Socials

About Scinai Immunotherapeutics

Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases. With a state-of-the-art facility for biopharmaceutical product development and manufacturing and highly experienced pharmaceutical industry leadership, Scinai offers end-to-end boutique CDMO services in parallel to developing its own pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized VHH antibody (NanoAb) pipeline targeting diseases with large unmet medical needs. Company website: www.scinai.com

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry
Director
Manager

Employees by Department

Scinai Immunotherapeutics has 17 employees across 6 departments.

Departments

Number of employees

Funding Data

Explore Scinai Immunotherapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date
Round
Amount
Link to Article
2023-10-1514$1,300,000
2024-01-2914$1,700,000
2024-09-1314$31,000,000
2025-07-1214$1,400,000

Funding Insights

$35,400,000

Total funding amount

$1,400,000

Most recent funding amount

4

Number of funding rounds

Scinai Immunotherapeutics Tech Stack

Discover the technologies and tools that power Scinai Immunotherapeutics's digital infrastructure, from frameworks to analytics platforms.

Modernizr

Modernizr

JavaScript libraries

reCAPTCHA

reCAPTCHA

Security

Google Maps

Google Maps

Maps

Microsoft 365

Microsoft 365

Email

Stimulus

Stimulus

JavaScript frameworks

HSTS

HSTS

Security

Zoho

Zoho

CRM

Google Analytics

Google Analytics

Analytics

Linkedin Insight Tag

Linkedin Insight Tag

Analytics

Adobe Fonts

Adobe Fonts

Font scripts

Squarespace Commerce

Squarespace Commerce

Ecommerce

Google Tag Manager

Google Tag Manager

Tag managers

Frequently asked questions

Scinai Immunotherapeutics is located in Mate Yehuda Regional Council, Jerusalem District, IL.
You can reach Scinai Immunotherapeutics at +97289302529.
Scinai Immunotherapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.
Scinai Immunotherapeutics has raised a total of $35,400,000 across 4 funding rounds. This investment has helped the company grow and expand its operations.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles